Literature DB >> 33363041

MR-Guided Radiotherapy for Prostate Cancer.

Boris R Tocco1, Amar U Kishan2, Ting Martin Ma2, Linda G W Kerkmeijer3, Alison C Tree1,4.   

Abstract

External beam radiotherapy remains the primary treatment modality for localized prostate cancer. The radiobiology of prostate carcinoma lends itself to hypofractionation, with recent studies showing good outcomes with shorter treatment schedules. However, the ability to accurately deliver hypofractionated treatment is limited by current image-guided techniques. Magnetic resonance imaging is the main diagnostic tool for localized prostate cancer and its use in the therapeutic setting offers anatomical information to improve organ delineation. MR-guided radiotherapy, with daily re-planning, has shown early promise in the accurate delivery of radiotherapy. In this article, we discuss the shortcomings of current image-guidance strategies and the potential benefits and limitations of MR-guided treatment for prostate cancer. We also recount present experiences of MR-linac workflow and the opportunities afforded by this technology.
Copyright © 2020 Tocco, Kishan, Ma, Kerkmeijer and Tree.

Entities:  

Keywords:  MR-guided radiotherapy; MR-linac; image-guided radiotherapy; online adaptive radiotherapy; prostate cancer

Year:  2020        PMID： 33363041      PMCID： PMC7757637          DOI： 10.3389/fonc.2020.616291

Source DB:  PubMed          Journal:  Front Oncol        ISSN： 2234-943X            Impact factor:   6.244


  72 in total

1.  Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.

Authors:  Anders Widmark; Adalsteinn Gunnlaugsson; Lars Beckman; Camilla Thellenberg-Karlsson; Morten Hoyer; Magnus Lagerlund; Jon Kindblom; Claes Ginman; Bengt Johansson; Kirsten Björnlinger; Mihajl Seke; Måns Agrup; Per Fransson; Björn Tavelin; David Norman; Björn Zackrisson; Harald Anderson; Elisabeth Kjellén; Lars Franzén; Per Nilsson
Journal:  Lancet       Date:  2019-06-18       Impact factor: 79.321

Review 2.  MRI-guided prostate adaptive radiotherapy - A systematic review.

Authors:  A J McPartlin; X A Li; L E Kershaw; U Heide; L Kerkmeijer; C Lawton; U Mahmood; F Pos; N van As; M van Herk; D Vesprini; J van der Voort van Zyp; A Tree; A Choudhury
Journal:  Radiother Oncol       Date:  2016-05-06       Impact factor: 6.280

3.  Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study.

Authors:  Chang-Juan Tao; Jun-Lin Yi; Nian-Yong Chen; Wei Ren; Jason Cheng; Stewart Tung; Lin Kong; Shao-Jun Lin; Jian-Ji Pan; Guang-Shun Zhang; Jiang Hu; Zhen-Yu Qi; Jun Ma; Jia-De Lu; Di Yan; Ying Sun
Journal:  Radiother Oncol       Date:  2015-05-26       Impact factor: 6.280

4.  Introduction: Systems for magnetic resonance image guided radiation therapy.

Authors:  Cynthia Ménard; Uulke van der Heide
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

5.  Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.

Authors:  Suki Gill; Jessica Thomas; Chris Fox; Tomas Kron; Aldo Rolfo; Mary Leahy; Sarat Chander; Scott Williams; Keen Hun Tai; Gillian M Duchesne; Farshad Foroudi
Journal:  Radiat Oncol       Date:  2011-10-28       Impact factor: 3.481

6.  Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer.

Authors:  M Daniel; P Kuess; P Andrzejewski; T Nyholm; T Helbich; S Polanec; F Dragschitz; G Goldner; D Georg; P Baltzer
Journal:  Strahlenther Onkol       Date:  2018-11-26       Impact factor: 3.621

7.  Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results.

Authors:  Jonathan Olivier; Laurent Basson; Philippe Puech; Thomas Lacornerie; Arnauld Villers; Jennifer Wallet; Eric Lartigau; David Pasquier
Journal:  Front Oncol       Date:  2019-02-15       Impact factor: 6.244

8.  Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.

Authors:  Alan Jay Katz; Josephine Kang
Journal:  Front Oncol       Date:  2014-09-02       Impact factor: 6.244

9.  1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.

Authors:  Filippo Alongi; Michele Rigo; Vanessa Figlia; Francesco Cuccia; Niccolò Giaj-Levra; Luca Nicosia; Francesco Ricchetti; Gianluisa Sicignano; Antonio De Simone; Stefania Naccarato; Ruggero Ruggieri; Rosario Mazzola
Journal:  Radiat Oncol       Date:  2020-03-23       Impact factor: 3.481

10.  Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study.

Authors:  Shyama U Tetar; Anna M E Bruynzeel; Swie S Oei; Suresh Senan; Tamara Fraikin; Berend J Slotman; R Jeroen A van Moorselaar; Frank J Lagerwaard
Journal:  Eur Urol Oncol       Date:  2020-06-12
View more
  15 in total

Review 1.  Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.

Authors:  William A Hall; Eric Paulson; X Allen Li; Beth Erickson; Christopher Schultz; Alison Tree; Musaddiq Awan; Daniel A Low; Brigid A McDonald; Travis Salzillo; Carri K Glide-Hurst; Amar U Kishan; Clifton D Fuller
Journal:  CA Cancer J Clin       Date:  2021-11-18       Impact factor: 508.702

2.  Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating.

Authors:  Yuqing Xiong; Moritz Rabe; Lukas Nierer; Maria Kawula; Stefanie Corradini; Claus Belka; Marco Riboldi; Guillaume Landry; Christopher Kurz
Journal:  Strahlenther Onkol       Date:  2022-09-23       Impact factor: 4.033

Review 3.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

4.  Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.

Authors:  Jörg Tamihardja; Sinan Cirsi; Patrick Kessler; Gary Razinskas; Florian Exner; Anne Richter; Bülent Polat; Michael Flentje
Journal:  Radiat Oncol       Date:  2021-10-26       Impact factor: 3.481

5.  Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review.

Authors:  Jim Zhong; Finbar Slevin; Andrew F Scarsbrook; Maria Serra; Ananya Choudhury; Peter J Hoskin; Sarah Brown; Ann M Henry
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

6.  HERMES: Delivery of a Speedy Prostate Cancer Treatment.

Authors:  R Westley; E Hall; A Tree
Journal:  Clin Oncol (R Coll Radiol)       Date:  2022-01-31       Impact factor: 4.925

7.  Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.

Authors:  Darren M C Poon; Bin Yang; Hui Geng; Oi Lei Wong; Sin Ting Chiu; Kin Yin Cheung; Siu Ki Yu; George Chiu; Jing Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-24       Impact factor: 4.553

Review 8.  MR-guided radiotherapy for prostate cancer: state of the art and future perspectives.

Authors:  Kobika Sritharan; Alison Tree
Journal:  Br J Radiol       Date:  2022-02-09       Impact factor: 3.039

9.  Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer.

Authors:  Hiroshi Tamura; Keiji Kobashi; Kentaro Nishioka; Takaaki Yoshimura; Takayuki Hashimoto; Shinichi Shimizu; Yoichi M Ito; Yoshikazu Maeda; Makoto Sasaki; Kazutaka Yamamoto; Hiroyasu Tamamura; Hidefumi Aoyama; Hiroki Shirato
Journal:  J Appl Clin Med Phys       Date:  2022-01-19       Impact factor: 2.102

Review 10.  [Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].

Authors:  Daniel Wegener; Daniel Zips; Cihan Gani; Simon Boeke; Konstantin Nikolaou; Ahmed E Othman; Haidara Almansour; Frank Paulsen; Arndt-Christian Müller
Journal:  Radiologe       Date:  2021-07-23       Impact factor: 0.635
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.